slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 96,091-96,120
Pages 3,953
Rows per page 30
Component
96,091-96,120 of 118,578
10
The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
25
The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
27
The slide uses a table to present a timeline of clinical milestones.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
01
argenx SE | Investor Presentation Deck | 22 slidesargenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
03
The slide uses a thematic background with a network/molecular graphic overlay.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
12
The slide uses a pyramid-like structure to display patient counts for different diseases, with 'clinical' highlighted in the top right.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
15
Includes immunofluorescence microscopy images and bar charts showing tidal volume and respiratory rate metrics.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
16
The slide illustrates the neuromuscular junction mechanism and the clinical trial progression from healthy volunteers to patients with CMS and MuSK MG.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a process flow diagram to illustrate the clinical trial methodology.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
09
argenx SE | Results Presentation Deck | 11 slidesargenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
08
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Why Now1 hit
10
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
22
Arrival | Results Presentation Deck | 28 slidesArrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
07
The slide serves as a visual anchor for the company's physical infrastructure.Astra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations 1 hit
08
The slide serves as a visual anchor for the company's physical operations.Astra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations 1 hit
17
Astra | Results Presentation Deck | 19 slidesAstra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations Beat · The Ask1 hit
03
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Current StateLoop · Golden Circle1 hit
05
The central diagram is a circular representation of three pillars (Healthy people, Healthy society, Healthy planet) with nine sub-focus areas.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Current StateLoop · Golden Circle1 hit
06
The slide uses a three-column layout to categorize sustainability metrics, with a sidebar for general strategy progress.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
07
The slide outlines the organization's ambition, focus areas, and specific country-level impact examples.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
10
Slide 10 of a presentation; includes footnotes explaining SET/SET-1 and specific targets.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
01
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
08
The slide uses a vertical timeline-like structure to highlight the 'Huge Need for Development' and a map/metric section for global impact.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate the progression of clinical validation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
12
The slide highlights that low doses (40 or 80 mg TID) of RL-007 show superior cognitive performance compared to higher doses and Pregabalin.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
22
The slide uses a split-layout with a left-hand sidebar for product specs and a right-hand main area for clinical evidence and trial design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
28
Uses a timeline-style visual to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit